Form 4: Beta Bionics Executive Sells Shares
Insider Transaction (Form 4)
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc, sold 370 shares of common stock on October 1, 2026 for $18.96 per share.
Summary
- Open-market sale: disposed of 370 Common Stock at $18.96 ($7,015) on October 1, 2026; holds 56,109 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $7,015 of stock on the open market.
Insider Transactions
Mark Hopman — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market sale | Common Stock | 370 | $19 | $7.0K | 56,109 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market sale (370 shares) |
Keywords
insider transaction, Form 4, BBNX, Beta Bionics, Inc., bearish, Mark Hopman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.